Derval O'Carroll
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Derval O'Carroll currently works at InflaRx NV, as SVP, Head-Global Regulatory Affairs & Compliance from 2022.
Ms. O'Carroll also formerly worked at Travere Therapeutics, Inc., as Senior Director-Regulatory Affairs from 2015 to 2017, Amryt Pharma Holdings Ltd., as Head-Regulatory Affairs, and Amryt Pharma Plc, as Head-Regulatory Affairs.
Ms. O'Carroll received her graduate degree and Masters Business Admin degree from University College Dublin.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INFLARX N.V. -.--% | 18-03-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| INFLARX N.V. | Compliance Officer | 01-01-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Algemeen Adviseur | 01-12-2017 |
| AMRYT PHARMA PLC | Algemeen Adviseur | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University College Dublin
University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
InflaRx NV
InflaRx NV BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company and develops and commercializing treatments for patients with rare & orphan diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau